Abstract
There are many lines of evidence supporting the idea that essential tremor is more than simply a monosymptomatic disorder and that all the clinical manifestations of this frequent disorder are sustained by a neurodegenerative process. The most important lines of evidence in favor of a neurodegenerative nature of essential tremor are: the anatomic and neuroimaging data demonstrating a pathologic process involving the cerebellum and/or brainstem; the progression of symptom severity with disease duration; and the lack of spontaneous remission of this condition. All of this evidence is supported by recent studies that are summarized in this review.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Many lines of evidence support the hypothesis that essential tremor (ET) is a progressive disease that is sustained by a neurodegenerative process. The neurodegenerative nature of ET is attributed to a pathologic process involving the cerebellum and/or brainstem (as demonstrated by anatomic and neuroimaging), progression of symptom severity with advancing disease, and the lack of spontaneous remission of this condition.
Pathologic evidence
The term ‘neurodegeneration’ refers to evidence of neuronal cell death. Probably, because of the general belief that ET is a functional disease (despite its high prevalence), very few studies on ET pathology had been performed until 2004, when a series of 20 subjects with a clinical diagnosis of ET, followed up for a period of 32 years, was described (Rajput et al. 2004). Despite the fact that no brain pathology was found in these ET patients, the following studies have demonstrated the presence of structural changes in the cerebellum, due to a reduction of Punkinje cells (PCs) and increases in torpedoes and hairy basket count, as well as structural changes in the brainstem due to an increased deposition of Lewy bodies (LB) in the locus coeruleus (LC) (Axelrad et al. 2008; Erickson-Davis et al. 2010; Louis et al. 2005, 2006a, 2006b, 2007, 2009a, 2011c; Shill et al. 2008). In this respect, a more relevant study by Axelrad et al. (2008) disclosed a seven times increased number of torpedoes in the PCs of ET subjects with respect to age-matched controls and two times with respect to Parkinson’s disease (PD) and Alzheimer’s disease (AD) patients. Recently, an increased number of torpedoes has been shown in the cerebellar vermis of ET brains, mainly in patients with voice, neck, and jaw tremor (Louis et al. 2011c). The torpedoes could be a marker of axonal damage or regenerative process, but this is still controversial; although the significance of torpedoes is not completely understood, converging evidence supports the hypothesis that they are an indirect sign of axonal PC degeneration; however, this sign is not specific to ET, and is present in other clearly neurodegenerative conditions, such as progressive supranuclear palsy, dentatorubropallidoluysian atrophy (Matsumoto et al. 1998), and fragile X associated tremor/ataxia (Greco et al. 2002). Consequently, the number of PCs as a marker of neurodegeneration in ET has been an obvious subject of study. The heterogeneity of populations studied and the difference in methods of analysis make the results obtained in these studies not easily comparable and sometimes contradictory (Louis et al. 2011d; Rajput and Rajput 2011; Rajput et al. 2011). At the Essential Tremor Centralized Brain Repository of New York, the largest series available of ET patient brains (N 33) was compared with 21 controls, with the result that at least two pathologic phenotypes emerged: a cerebellar one (involving 75 % of patients) with reduced PCs and increased torpedoes, characterized by younger age of tremor onset, gait difficulty, and positive family history of ET; and an LB phenotype, with LBs mainly located in the LC (Louis et al. 2007). One year later, a clear reduction in PC linear density in a group of eight ET patients without evidence of LBs compared with 11 controls was confirmed (Axelrad et al. 2008). The reason for the PC reduction in one group of ET patients and the increase in LBs in the LC in another group of ET patients has not yet been clinically defined, but it does confirm the heterogeneity of this disease, which clinicians are already well aware of.
Major criticisms of the above-mentioned anatomopathologic studies are the advanced age of patients evaluated and the occurrence of pathologic aspects that could also be detected in subjects without evidence of neurologic disorders. In response to these criticisms, firstly, most of the listed studies that comprised age-matched normal subjects and compared with them ET patients, showed a decrease of PCs and an increase of torpedoes in a subgroup of patients or an increase of LBs in another subgroup of patients; secondly, the consideration that LBs are present in about 20 % of ET patients but also in elderly controls in a similar percentage does not take into account the anatomic distribution of LBs. As observed by Louis (2010), the majority of LBs in ET patients is located in the LC, while in elderly normal subjects, the LC is only marginally involved.
Neuroimaging
Neuroimaging studies represent a surrogate in vivo biomarker of degeneration in various neurodegenerative disorders, and despite the need for further and wider studies, many recent reports suggest the presence of abnormalities in the cerebellum as well as other brain structures of ET patients.
Since postmortem studies provided evidence of degenerative changes in the cerebellum in many cases of ET, several imaging studies focused on visualizing cerebellar involvement in ET. Whereas some pioneer studies did not detect structural changes in the cerebellum, by magnetic resonance imaging (MRI) spectroscopy, a reduction in N-acetylaspartate/creatine and N-acetylaspartate/choline ratios was reported in cerebellar hemispheres (Louis et al. 2002; Pagan et al. 2003). Voxel-based morphometry studies using 1.5 T MRI (Daniels et al. 2006; Quattrone et al. 2008) led to controversial results; but recently, by means of 3 T MRI, structural white and gray abnormalities have been detected in ET patients in the cerebellum rather than cerebral areas. In particular, Benito-León et al. (2009) were able to report gray matter changes in the bilateral cerebellum and parietal and frontal lobes, and white matter changes in the frontal, parietal, and limbic lobes in 19 ET patients compared with 20 controls. Similarly, a recent report of 20 ET patients and 20 controls found scattered areas of cerebral and cerebellar atrophy (Bagepally et al. 2011); furthermore, a significant relationship between gray matter atrophy and tremor severity was observed in this study, suggesting that tremor generation is sustained by the degeneration rather than by dysfunction of cerebellar circuits. Further new insights came from diffusion tensor imaging studies: although a previous study did not find any significant difference between ET patients and controls (Martinelli et al. 2007), more recently, another report (Shin et al. 2008) showed a reduction of fractional anisotropy in the cerebellum and red nucleus. Again, by using 3 T MRI, significant cerebellar changes, as reduction of fractional anisotropy, were reported in patients with familial ET in the dentate nucleus and superior cerebellar peduncles (Nicoletti et al. 2010); moreover, a significant correlation between reduction of fractional anisotropy and ET disease duration was reported in this study. Finally, Klein et al. (2011), by means of a whole-brain analysis with tract-based spatial statistic, confirmed by voxel-wise analysis, have found evidence for localized pathology of cerebellar circuits and more general alterations of white matter in both motor and non-motor structures, supporting the impairment of neuronal fiber integrity in ET.
Progression of signs and symptoms in ET
The natural history of ET has not been completely defined, probably because of the heterogeneity of disease, but given the current evidence, three main observations can be made: age is a risk factor for ET; ET is a slowly progressive disorder; and clinical characteristics could differ at different stages of the disease. Moreover, to the best of our knowledge, there are no reported cases of spontaneous remission of ET.
As with either PD or AD, the incidence of ET is higher in elderly patients, ranging from 58.6 up to 84.3 per 100,000 individuals, which increases with age, suggesting that older age is an important risk factor for ET (Rajput et al. 1984). A few longitudinal studies have addressed the question of disease progression; an increase of tremor amplitude of about 30 % in a period of 4 years paralleled by a reduction in tremor frequencies has been detected by means of electrophysiologic evaluation (Elbe Elble 2000), and age and disease duration have been independently related to disease severity as assessed by a tremor scale (Louis et al. 2003). This evidence might suggest that a worsening of ET usually appears with disease duration, independent of age, and the higher rate of disease progression in older onset ET (Louis et al. 2009b) might indicate an age-related process of brain damage. A few longitudinal data (Louis et al. 2011b; Putzke et al. 2006) have defined a small, but significant, increase in tremor severity in ET patients estimated in terms of 12 % in a year from baseline evaluation in one series, and between 3.1 and 5.3 % in a recent paper assessing disease progression of tremor severity in ET patients followed up for many years. Moreover, it should be recalled that these changes in disease severity are more pronounced in elderly patients (Louis et al. 2009b). In addition, there are suggestions that despite a classic onset of tremor in both hands, later stages are characterized by the diffusion to other anatomic regions (mainly the head) (Louis 2005). Disease progression is not only characterized by the possible speading of tremor to the head or the increase in tremor amplitude, but also by the occurrence of signs of cerebellar involvement.
The neurologic disorders associated with ET include a wide spectrum of cerebellar symptoms, such as gait ataxia (Louis et al. 2010b, Rao et al. 2011), dysarthria (Kronenbuerger et al. 2009), oculomotor abnormalities (Helmchen et al. 2003), as well as deficits in hand–eye coordination (Trillenberg et al. 2006); however, these findings are not surprising since the possible presence of intention tremor among phenotypes of ET also represents a link between such disease and cerebellar dysfunction (Deuschl et al. 2000).
Furthermore gait ataxia, observed in 50 % of ET patients, is especially present in those individuals with longer disease duration and more severe tremor, and it is closely related to aging and tremor duration (Singer et al. 1994). The finding that cerebellar dysfunction is associated with ET in the advanced stages (Deuschl et al. 2000; Helmchen et al. 2003; Stolze et al. 2001) might indicate that the spreading of the disease to the cerebellum is a sign of progression, thus supporting the neurodegenerative hypothesis.
Klebe et al. (2005) have demonstrated that gait ataxia could be reversed in alcohol-responsive tremor patients by alcohol intake. Although this finding could be considered as evidence supporting the functional hypothesis, it should also be remembered that the neurochemical deficit sustaining ataxia and tremor could be the same, i.e. a deficit in gamma-amminobutyric acid (GABA) cerebellar neurotransmission; thus, tremor and ataxia could respond to GABAergic enhancement operated by ethanol, as in PD, most of the symptoms are responsive to dopamine replacement therapy.
A criticism has been made that these subclinical abnormalities are very mild and not clinically significant, but this observation does not invalidate their role in supporting a progressive cerebellar degeneration associated with ET.
Rest tremor has been described in 18.8 % of ET patients (Cohen et al. 2003); in a similar study, rest tremor was associated with more long-standing disease, more severe, and more disseminated tremor. Even if the substrate of resting tremor in ET is still unknown (Louis et al. 2011a), it could be due to pathologic spreading to extracerebellar circuits in patients with severe, long-standing, and disseminated disease.
Several papers have explored the cognitive profile of ET patients. Gasparini et al. (2001) have investigated the frontal lobe function in ET and PD patients, reporting that the ET group scored better on the tests than the PD group, but worse than the controls. Further studies have also shown that ET patients have impaired memory function (Lombardi et al. 2001) in addition to impaired executive function (Duane and Vermilion 2002). However, most of the neuropsychologic studies were limited due to the number of patients recruited, the lack of a control group, and the psychometric measures used were widely heterogeneous and not comparable. Despite these limitations, there is convincing evidence that ET patients have cognitive deficits, in particular, attention, executive function, verbal fluency, and several memory functions, including working memory, are mildly impaired in ET patients, whereas visuospatial function is relatively spared. The degree of cognitive impairment in ET is mild, related to age, and is sustained by a dysfunction in the dorsolateral prefrontal cortex and its connection to other brain areas, including the cerebral–cerebellar loop (Cerasa et al. 2010). Evidence has emerged, in a longitudinal study (Louis et al. 2010a), that the cognitive deficits in ET are not static, but seem to be progressing at a faster rate than occurs in normal elderly individuals, which supports the degenerative nature of ET.
The neuropsychologic evidence of a clear-cut impairment in many cognitive functions in ET patients is possibly due to impairment of the cerebello-thalamo-frontal connection as well as to direct impairment of other cortical and subcortical structures. This suggests that the clinical spectrum of symptoms in ET patients is to be widely expanded to other non-motor symptoms, as is the case for PD.
References
Axelrad JE, Louis ED, Honig LS et al (2008) Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol 65:101–107
Bagepally BS, Bhatt MD, Chandran V et al. (2011) Decrease in cerebral and cerebellar gray matter in essential tremor: a voxel-based morphometric analysis under 3T MRI. J Neuroimaging. doi:10.1111/j.1552-6569.2011.00598.x. (E-pub ahead of print)
Benito-León J, Alvarez-Linera J, Hernández-Tamames JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Louis ED (2009) Brain structural changes in essential tremor: voxel-based morphometry at 3-tesla. J Neurol Sci 287:138–142
Cerasa A, Passamonti L, Novellino F et al (2010) Fronto-parietal overactivation in patients with essential tremor during stroop task. NeuroReport 21:148–151
Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED (2003) Rest tremor in patients with essential tremor prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol 60:405–410
Daniels C, Peller M, Wolff S et al (2006) Voxel-based morphometry shows no decreases in cerebellar gray matter volume in essential tremor. Neurology 67:1452–1456
Deuschl G, Wenzelburger R, Löffler K, Raethjen J, Stolze H (2000) Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain 123:1568–1580
Duane DD, Vermilion KJ (2002) Cognitive deficits in patients with essential tremor. Neurology 58:1706
Elble RJ (2000) Essential tremor frequency decreases with time. Neurology 55:1547–1551
Erickson-Davis CR, Faust PL, Vonsattel JP, Gupta S, Honig LS, Louis ED (2010) “Hairy baskets’’ associated with degenerative purkinje cell changes in essential tremor. J Neuropathol Exp Neurol 69:262–271
Gasparini M, Bonifati V, Fabrizio E et al (2001) Frontal lobe dysfunction in essential tremor a preliminary study. J Neurol 248:399–402
Greco CM, Hagerman RJ, Tassone F et al (2002) Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760–1771
Helmchen C, Hagenow A, Miesner J et al (2003) Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. Brain 126:1319–1332
Klebe S, Stolze H, Grensing K, Volkmann J, Wenzelburger R, Deuschl G (2005) Influence of alcohol on gait in patients with essential tremor. Neurology 65:96–101
Klein JC, Lorenz B, Kang JS et al (2011) Diffusion tensor imaging of white matter involvement in essential tremor. Hum Brain Mapp 32:890–896
Kronenbuerger M, Konczak J, Ziegler W et al (2009) Balance and motor speech impairment in essential tremor. Cerebellum 8:389–398
Lombardi WJ, Woolston DJ, Roberts JW, Gross RE (2001) Cognitive deficits in patients with essential tremor. Neurology 57:785–790
Louis ED (2005) Essential tremor. Lancet Neurol 4:100–110
Louis ED (2010) Essential tremor. Evolving clinicopathological concepts in an era of intensive post-mortem enquiry. Lancet Neurol 9:613–622
Louis ED, Shungu DC, Chan S, Mao X, Jurewicz EC, Watner D (2002) Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 333:17–20
Louis ED, Jurewicz EC, Watner D (2003) Community-based data on associations of disease duration and age with severity of essential tremor: implications for disease pathophysiology. Mov Disord 18:90–93
Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB (2005) Essential tremor associated with focal nonnigral lewy bodies: a clinicopathologic study. Arch Neurol 62:1004–1007
Louis ED, Vonsattel JP, Honig LS et al (2006a) Essential tremor associated with pathologic changes in the cerebellum. Arch Neurol 63:1189–1193
Louis ED, Vonsattel JP, Honig LS, Ross GW, Lyons KE, Pahwa R (2006b) Neuropathologic findings in essential tremor. Neurology 66:1756–1759
Louis ED, Faust PL, Vonsattel JP et al (2007) Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 130:3297–3307
Louis ED, Faust PL, Vonsattel JP et al (2009a) Torpedoes in Parkinson’s disease, Alzheimer’s disease, essential tremor, and control brains. Mov Disord 24:1600–1605
Louis ED, Faust PL, Vonsattel JP et al (2009b) Older onset essential tremor: more rapid progression and more degenerative pathology. Mov Disord 24:1606–1612
Louis ED, Benito-León J, Vega-Quiroga S, Bermejo-Pareja F, Neurological Disorders in Central Spain (NEDICES) Study Group (2010a) Faster rate of cognitive decline in essential tremor cases than controls a prospective study. Eur J Neurol 17:1291–1297
Louis ED, Rios E, Rao AK (2010b) Tandem gait performance in essential tremor: clinical correlates and association with midline tremors. Mov Disord 25:1633–1638
Louis ED, Asabere N, Agnew A et al (2011a) Rest tremor in advanced essential tremor: a post-mortem study of nine cases. J Neurol Neurosurg Psychiatry 82:261–265
Louis ED, Agnew A, Gillman A, Gerbin M, Viner AS (2011b) Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor cases. J Neurol Neurosurg Psychiatry 82:761–765
Louis ED, Faust PL, Ma KJ, Yu M, Cortes E, Vonsattel JP (2011c) Torpedoes in the cerebellar vermis in essential tremor cases vs. controls. Cerebellum (Epub ahead of print)
Louis ED, Faust PL, Vonsattel JP (2011d) Purkinje cell loss is a characteristic of essential tremor. Parkinsonism Relat Disord 17:406–409
Martinelli P, Rizzo G, Manners D et al (2007) Diffusion-weighted imaging study of patients with essential tremor. Mov Disord 22:1182–1185
Matsumoto R, Nakano I, Arai N, Oda M, Yagishita S, Hashizume Y (1998) Loss of the dentate nucleus neurons is associated with torpedo formation: a morphometric study in progressive supra-nuclear palsy and dentatorubro-pallidoluysian atrophy. Acta Neuropathol 95:149–153
Nicoletti G, Manners D, Novellino F et al (2010) Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology 74:988–994
Pagan FL, Butman JA, Dambrosia JM, Hallett M (2003) Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 60:1344–1347
Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ (2006) Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry 77:1235–1237
Quattrone A, Cerasa A, Messina D et al (2008) Essential head tremor is associated with cerebellar vermis atrophy: a volumetric and voxel-based morphometry MR imaging study. AJNR Am J Neuroradiol 29:1692–1697
Rajput AH, Rajput A (2011) Significance of cerebellar purkinje cell loss to pathogenesis of essential tremor. Parkinsonism Relat Disord 17:410–412
Rajput AH, Offord KP, Beard CM, Kurland LT (1984) Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry 47:466–470
Rajput A, Robinson CA, Rajput AH (2004) Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 62:932–936
Rajput AH, Robinson CA, Rajput ML, Rajput A (2011) Cerebellar Purkinje cell loss is not pathognomonic of essential tremor. Parkinsonism Relat Disord 17:16–21
Rao AK, Gillman A, Louis ED (2011) Quantitative gait analysis in essential tremor reveals impairments that are maintained into advanced age. Gait Posture 34:65–70
Shill HA, Adler CH, Sabbagh MN et al (2008) Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 70:1452–1455
Shin DH, Han BS, Kim HS, Lee PH (2008) Diffusion tensor imaging in patients with essential tremor. AJNR Am J Neuroradiol 29:151–153
Singer C, Sanchez-Ramos J, Weiner W (1994) Gait abnormality in essential tremor. Mov Disord 9:193–196
Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G (2001) The gait disorder of advanced essential tremor. Brain 124:2278–2286
Trillenberg P, Führer J, Sprenger A et al (2006) Eye–hand coordination in essential tremor. Mov Disord 21:373–379
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bonuccelli, U. Essential tremor is a neurodegenerative disease. J Neural Transm 119, 1383–1387 (2012). https://doi.org/10.1007/s00702-012-0878-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-012-0878-8